Safety and efficacy of long-acting CAB and RPV as two drug IM maintenance therapy: LATTE-2 week 96 results. MOAX0205LB Conference Poster 2017 Congress communication uri icon

authors

  • B. Clotet
  • D. Dorey
  • D. Margolis
  • D. Podzamczer
  • G.J. Richmond
  • GUTIERREZ RODERO, FELIX
  • H.-J. Stellbrink
  • J. Eron
  • J. Gonzalez-Garcia
  • J.B. Angel
  • K.C. Sutton
  • K.Y. Smith
  • L. Sloan
  • P.E. Williams
  • T. Lutz
  • Y.Yazdanpanah

publication date

  • 2017